Read + Share
Zhang Q, Wang Z, Yao W, Wang S, et al. A randomized, multicenter phase III Study of once-per-cycle administration of
efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of
chemotherapy-induced neutropenia in patients with breast cancer. BMC Cancer 2024;24:1143.
PMID: 39272058
|
 |
|
